Your browser doesn't support javascript.
loading
Serum macrophage inflammatory protein 3α levels predict the severity of HBV-related acute-on-chronic liver failure.
Xin, Jiaojiao; Ding, Wenchao; Hao, Shaorui; Chen, Xin; Zhang, Jianing; Jiang, Longyan; Zhou, Qian; Shi, Dongyan; Zhang, Liyuan; Xu, Xiaowei; Cao, Hongcui; Li, Lanjuan; Li, Jun.
Afiliación
  • Xin J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ding W; Systems Biology Division, Zhejiang-California International Nanosystems Institute, Zhejiang University, Hangzhou, China.
  • Hao S; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Chen X; Department of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
  • Zhang J; Department of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
  • Jiang L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhou Q; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shi D; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xu X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cao H; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Li J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Gut ; 65(2): 355-7, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26041751

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores / Quimiocina CCL20 / Insuficiencia Hepática Crónica Agudizada / Hepatitis B Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Gut Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores / Quimiocina CCL20 / Insuficiencia Hepática Crónica Agudizada / Hepatitis B Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Gut Año: 2016 Tipo del documento: Article País de afiliación: China